Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...
Zacks.com on MSN6d
MYGN Stock Gains Following the Launch of Know More SoonerMyriad Genetics, Inc. MYGN recently launched a new educational website, Know More Sooner, which provides comprehensive ...
We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...
The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...
Trading Advice for Myriad Genetics Inc. MYGN including day trading swing trading and long term investing plans for MYGN ...
Myriad Genetics, Inc.’s MYGN MyRisk Hereditary Cancer Test with RiskScore study has been named as one of its top 10 significant advances in genomic medicine by the American Journal of Human ...
SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...
Myriad Genetics, Inc. MYGN recently launched a new educational website, Know More Sooner, which provides comprehensive information about reproductive and prenatal genetic testing. The latest ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it will unveil groundbreaking research at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback